VITAMIN C (ASCORBIC ACID) BENEFITS

KEY BENEFITS OF VITAMIN C

    • Supports skin health
    • Supports general immune health
    • Supports antioxidant defenses

ABOUT VITAMIN C

In addition to citrus fruits (oranges, grapefruits), peppers, broccoli, brussels sprouts, and strawberries, vitamin C is also known as ascorbic acid or ascorbate.

 

Due to the fact that the human body cannot synthesize vitamin C, it must be obtained from food, vitamin C is an essential vitamin.

 

A potent antioxidant, vitamin C plays a crucial role in the cellular antioxidant defense system.

 

The ascorbate form of vitamin C is also used to produce the enzymes necessary to make collagen, carnitine, and dopamine.


VITAMIN C FULL BENEFITS

Antioxidant defenses

 

  • Free radical scavenger [1]
  • Supports antioxidant defenses [5]
  • Counters oxidative stress and oxidative cellular damage [1,5]

 

Brain and cognitive function

 

  • Supports memory and learning [6]
  • Supports cognitive health [6]
  • Supports L-DOPA synthesis [7]
  • Cofactor for dopamine-β-hydroxylase (which converts dopamine to noradrenaline) [2]
  • Supports dopamine signaling [8]
  • Supports noradrenaline signaling [9]
  • Influences glutamate signaling [10–12]
  • Influences serotonin (5-HT) signaling [13]
  • Supports acetylcholine signaling [9,14,15]
  • Supports the differentiation of neuronal progenitors [16]
  • Supports neuronal myelination [2,17–19]
  • Influences neuronal calcium channel activity [20]
  • Supports neuroendocrine signaling [21–26]
  • Supports antioxidant defenses in the brain [5,27]
  • Supports neuroprotective functions [5,11,27–30]

 

Immune function

 

  • Supports general immune health [31,32]
  • Supports innate immunity [4,33–35]
  • Supports adaptive immunity [4,33,35,36]

 

Skin health

 

  • Supports skin antioxidant defenses [37]
  • Supports skin in adapting to UV radiation [38–40]
  • Supports collagen synthesis [41]
  • Supports elastin synthesis [42]

 

Mood

 

  • Supports positive affect [5,27,43–47]

 

Vascular function

 

  • Supports endothelial nitric oxide synthase activity and NO production [48–50]

 

VITAMIN C (ASCORBIC ACID) CAN BE FOUND IN:

Morning Momentum

Get Instant Access To A Simple, Proven System That Has Helped

THOUSANDS of People

IGNITE Their Health and Energy

to Create The Life They Deserve!

Learn More


REFERENCES

[1]S.J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S.K. Dutta, M. Levine, J. Am. Coll. Nutr. 22 (2003) 18–35.

[2]R. Figueroa-Méndez, S. Rivas-Arancibia, Front. Physiol. 6 (2015) 397.

[3]S.J. Ballaz, G.V. Rebec, Pharmacol. Res. 146 (2019) 104321.

[4]M. Levine, C. Conry-Cantilena, Y. Wang, R.W. Welch, P.W. Washko, K.R. Dhariwal, J.B. Park, A. Lazarev, J.F. Graumlich, J. King, L.R. Cantilena, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3704–3709.

[5]M. Moretti, A. Colla, G. de Oliveira Balen, D.B. dos Santos, J. Budni, A.E. de Freitas, M. Farina, A.L. Severo Rodrigues, J. Psychiatr. Res. 46 (2012) 331–340.

[6]M. Parle, D. Dhingra, J. Pharmacol. Sci. 93 (2003) 129–135.

[7]G. Seitz, S. Gebhardt, J.F. Beck, W. Böhm, H.N. Lode, D. Niethammer, G. Bruchelt, Neurosci. Lett. 244 (1998) 33–36.

[8]R.C. Pierce, J.K. Rowlett, G.V. Rebec, M.T. Bardo, Brain Res. 688 (1995) 21–26.

[9]C.H. Kuo, F. Hata, H. Yoshida, A. Yamatodani, H. Wada, Life Sci. 24 (1979) 911–915.

[10]M.I. Sandstrom, G.V. Rebec, BMC Neurosci. 8 (2007) 32.

[11]M.D. Majewska, J.A. Bell, E.D. London, Brain Res. 537 (1990) 328–332.

[12]E.A. Kiyatkin, G.V. Rebec, Brain Res. 812 (1998) 14–22.

[13]R.D. Todd, P.A. Bauer, J. Neurochem. 50 (1988) 1505–1512.

[14]C.H. Kuo, H. Yoshida, Jpn. J. Pharmacol. 30 (1980) 481–492.

[15]D. Dhingra, M. Parle, S.K. Kulkarni, J. Med. Food 9 (2006) 281–283.

[16]J. Yan, L. Studer, R.D.G. McKay, J. Neurochem. 76 (2009) 307–311.

[17]C.F. Eldridge, M.B. Bunge, R.P. Bunge, P.M. Wood, The Journal of Cell Biology 105 (1987) 1023–1034.

[18]J.-Y. Lee, M.-Y. Chang, C.-H. Park, H.-Y. Kim, J.-H. Kim, H. Son, Y.-S. Lee, S.-H. Lee, J. Neurosci. Res. 73 (2003) 156–165.

[19]K. Oyarce, C. Silva-Alvarez, L. Ferrada, F. Martínez, K. Salazar, F. Nualart, Mol. Neurobiol. 55 (2018) 1136–1149.

[20]M.T. Nelson, P.M. Joksovic, P. Su, H.-W. Kang, A. Van Deusen, J.P. Baumgart, L.S. David, T.P. Snutch, P.Q. Barrett, J.-H. Lee, C.F. Zorumski, E. Perez-Reyes, S.M. Todorovic, J. Neurosci. 27 (2007) 12577–12583.

[21]J.L. Bény, A.J. Baertschi, Endocrinology 109 (1981) 813–817.

[22]M. Kawaguchi, F. Hayakawa, Y. Kamiya, T. Fujii, J. Ito, N. Sakuma, T. Fujinami, Life Sci. 52 (1993) 975–979.

[23]B.T. Miller, T.J. Cicero, Brain Res. Bull. 19 (1987) 95–99.

[24]Z. Yang, D.L. Copolov, A.T. Lim, Brain Res. 706 (1996) 243–248.

[25]S. Karanth, W.H. Yu, A. Walczewska, C.A. Mastronardi, S.M. McCann, Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11783–11788.

[26]S. Karanth, W.H. Yu, A. Walczewska, C. Mastronardi, S.M. McCann, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1891–1896.

[27]M. Moretti, J. Budni, D.B. Dos Santos, A. Antunes, J.F. Daufenbach, L.M. Manosso, M. Farina, A.L.S. Rodrigues, J. Mol. Neurosci. 49 (2013) 68–79.

[28]S. Rosales-Corral, D.-X. Tan, R.J. Reiter, M. Valdivia-Velázquez, G. Martínez-Barboza, J.P. Acosta-Martínez, G.G. Ortiz, J. Pineal Res. 35 (2003) 80–84.

[29]M.D. Majewska, J.A. Bell, Neuroreport 1 (1990) 194–196.

[30]A. Atlante, S. Gagliardi, G.M. Minervini, M.T. Ciotti, E. Marra, P. Calissano, J. Neurochem. 68 (1997) 2038–2045.

[31]N. Mikirova, R. Hunninghake, Med. Sci. Monit. 20 (2014) 725–732.

[32]C.S. Johnston, G.M. Barkyoumb, S.S. Schumacher, Nutrients 6 (2014) 2572–2583.

[33]P. Tauler, A. Aguiló, I. Gimeno, A. Noguera, A. Agustí, J.A. Tur, A. Pons, Free Radic. Res. 37 (2003) 931–938.

[34]G. Heuser, A. Vojdani, Immunopharmacol. Immunotoxicol. 19 (1997) 291–312.

[35]R. Anderson, R. Oosthuizen, R. Maritz, A. Theron, A.J. Van Rensburg, Am. J. Clin. Nutr. 33 (1980) 71–76.

[36]W. Prinz, R. Bortz, B. Bregin, M. Hersch, Int. J. Vitam. Nutr. Res. 47 (1977) 248–257.

[37]A.-C. Lauer, N. Groth, S.F. Haag, M.E. Darvin, J. Lademann, M.C. Meinke, Skin Pharmacol. Physiol. 26 (2013) 147–154.

[38]B. Eberlein-König, M. Placzek, B. Przybilla, J. Am. Acad. Dermatol. 38 (1998) 45–48.

[39]M. Placzek, S. Gaube, U. Kerkmann, K.-P. Gilbertz, T. Herzinger, E. Haen, B. Przybilla, J. Invest. Dermatol. 124 (2005) 304–307.

[40]H. Mireles-Rocha, I. Galindo, M. Huerta, B. Trujillohernández, A.E. T, R. Cortés-Franco, Acta Derm. Venereol. 82 (2002) 21–24.

[41]D. Crisan, I. Roman, M. Crisan, K. Scharffetter-Kochanek, R. Badea, Clin. Cosmet. Investig. Dermatol. 8 (2015) 463–470.

[42]A. Hinek, H.J. Kim, Y. Wang, A. Wang, T.F. Mitts, J. Dermatol. Sci. 75 (2014) 173–182.

[43]S. Brody, Biol. Psychiatry 52 (2002) 371–374.

[44]J.M. Pullar, A.C. Carr, S.M. Bozonet, M.C.M. Vissers, Antioxidants (Basel) 7 (2018).

[45]S. Gariballa, Int. J. Vitam. Nutr. Res. 84 (2014) 12–17.

[46]M. Moretti, J. Budni, C.M. Ribeiro, A.L.S. Rodrigues, Eur. J. Pharmacol. 687 (2012) 21–27.

[47]R.W. Binfaré, A.O. Rosa, K.R. Lobato, A.R.S. Santos, A.L.S. Rodrigues, Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009) 530–540.

[48]L.V. d’Uscio, S. Milstien, D. Richardson, L. Smith, Z.S. Katusic, Circ. Res. 92 (2003) 88–95.

[49]R. Heller, A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, E.R. Werner, J. Biol. Chem. 276 (2001) 40–47.

[50]A. Huang, J.A. Vita, R.C. Venema, J.F. Keaney Jr, J. Biol. Chem. 275 (2000) 17399–17406.